GLP-1s

#### Common GLP-1 Agonists

Several GLP-1 receptor agonists are currently available on the market, including:

- **Liraglutide (Victoza)**: A daily injection that has shown effectiveness in lowering blood sugar and aiding weight loss.

- **Dulaglutide (Trulicity)**: A weekly injection that has similar benefits with the added advantage of convenience.

- **Semaglutide (Ozempic)**: Another weekly option, with studies suggesting significant weight loss and cardiovascular benefits.

- **Exenatide (Byetta and Bydureon)**: Available as both a daily and weekly injection, offering flexibility in dosing.

#### Potential Side Effects

While GLP-1 agonists are generally well-tolerated, they can have side effects, including:

- **Gastrointestinal Issues**: Nausea, vomiting, and diarrhea are the most common side effects, particularly when starting treatment.

- **Pancreatitis**: There is a potential risk of pancreatitis, which requires monitoring and prompt reporting of abdominal pain.

- **Kidney Concerns**: Some patients may experience changes in kidney function, particularly those with pre-existing kidney issues.